RE: MELLON FINANCIALI wonder if Mellon is a front man for a PHARMA.Owning 21% and picking up cheap shares as we meamble along the summer hiatus would give said PHARMA a huge advantage in staging a cheap takeover.
I've held the opinion for some time that if there is the slightest hint of a successful outcome for this treatment it will be taken off the table before good news drives up the price.
In the event the above takes place DON'T expect management to protect the shareholders.